First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO™ System for Functional Mitral Regurgitation (FMR)

Presenter: Stephen G. Worthley

REGISTER for free or LOG IN to view this content

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO™ System for Functional Mitral Regurgitation (FMR)

We Recommend